[go: up one dir, main page]

MX2018003640A - Espuma quimica sin enguaje que contiene trifaroteno y su uso en el tratamiento de la ictiosis. - Google Patents

Espuma quimica sin enguaje que contiene trifaroteno y su uso en el tratamiento de la ictiosis.

Info

Publication number
MX2018003640A
MX2018003640A MX2018003640A MX2018003640A MX2018003640A MX 2018003640 A MX2018003640 A MX 2018003640A MX 2018003640 A MX2018003640 A MX 2018003640A MX 2018003640 A MX2018003640 A MX 2018003640A MX 2018003640 A MX2018003640 A MX 2018003640A
Authority
MX
Mexico
Prior art keywords
ichthyosis
treatment
composition
trifarotene
foam containing
Prior art date
Application number
MX2018003640A
Other languages
English (en)
Other versions
MX382168B (es
Inventor
Nadau-Fourcade Karine
Christophe BUGE Jean-
Original Assignee
Galderma Res & Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Galderma Res & Dev filed Critical Galderma Res & Dev
Publication of MX2018003640A publication Critical patent/MX2018003640A/es
Publication of MX382168B publication Critical patent/MX382168B/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/12Aerosols; Foams
    • A61K9/122Foams; Dry foams
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/192Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/20Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/203Retinoic acids ; Salts thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/4021-aryl substituted, e.g. piretanide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0002Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007Effervescent
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/02Suppositories; Bougies; Bases therefor; Ovules
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/06Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/12Aerosols; Foams
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Cosmetics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

La presente invención se refiere a una composición autoespumante que contiene trifaroteno, destinada a la aplicación tópica sin enjuague, que comprende: - al menos una composición intermediaria B que comprende un agente generador de gas, - al menos una composición intermedia A que comprende un agente activador para el agente generador de gas, y - el trifaroteno o una de sus sales farmacéuticamente aceptables contenido en al menos una de las composiciones intermediarias A y B. La composición de acuerdo a la invención está destinada al tratamiento de la ictiosis. La presente invención se refiere igualmente a un kit o un recipiente único con varios compartimientos que contienen una composición de este tipo.
MX2018003640A 2015-09-29 2016-09-27 Espuma quimica sin enguaje que contiene trifaroteno y su uso en el tratamiento de la ictiosis. MX382168B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR1559201A FR3041535B1 (fr) 2015-09-29 2015-09-29 Mousse chimique non rincee contenant du trifarotene, et son utilisation dans le traitement de l'ichtyose.
PCT/EP2016/073014 WO2017055297A1 (fr) 2015-09-29 2016-09-27 Mousse chimique non rincée contenant du trifarotène, et son utilisation dans le traitement de l'ichtyose

Publications (2)

Publication Number Publication Date
MX2018003640A true MX2018003640A (es) 2018-04-30
MX382168B MX382168B (es) 2025-03-13

Family

ID=54848734

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2018003640A MX382168B (es) 2015-09-29 2016-09-27 Espuma quimica sin enguaje que contiene trifaroteno y su uso en el tratamiento de la ictiosis.

Country Status (9)

Country Link
US (1) US11020348B2 (es)
EP (1) EP3355859A1 (es)
JP (1) JP2018529773A (es)
KR (1) KR20180057713A (es)
CN (1) CN108289838A (es)
AU (1) AU2016330790B2 (es)
FR (1) FR3041535B1 (es)
MX (1) MX382168B (es)
WO (1) WO2017055297A1 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3641725A1 (en) 2017-06-23 2020-04-29 The Procter and Gamble Company Composition and method for improving the appearance of skin
US11622963B2 (en) 2018-07-03 2023-04-11 The Procter & Gamble Company Method of treating a skin condition
US10959933B1 (en) 2020-06-01 2021-03-30 The Procter & Gamble Company Low pH skin care composition and methods of using the same
EP4157206A1 (en) 2020-06-01 2023-04-05 The Procter & Gamble Company Method of improving penetration of a vitamin b3 compound into skin

Family Cites Families (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6649186B1 (en) 1996-09-20 2003-11-18 Ethypharm Effervescent granules and methods for their preparation
EP1043023B1 (en) 1997-11-07 2008-07-09 Medion Research Laboratories Inc. Viscous compositions containing carbon dioxide
FR2761600B1 (fr) 1998-06-19 2000-03-31 Oreal Composition moussante pour le lavage et le traitement des cheveux et/ou du cuir chevelu a base d'un principe actif, d'un tensioactif anionique, d'un tensioactif amphotere et d'un agent propenetrant
AUPP583198A0 (en) 1998-09-11 1998-10-01 Soltec Research Pty Ltd Mousse composition
US5952372A (en) 1998-09-17 1999-09-14 Mcdaniel; William Robert Method for treating rosacea using oral or topical ivermectin
US6177092B1 (en) 1998-11-10 2001-01-23 Color Access, Inc. Self-foaming cleansing systems
US6133310A (en) 1999-08-26 2000-10-17 Parks; L. Dean Method of treatment of rosacea
US6399652B1 (en) 2000-06-29 2002-06-04 L. Dean Parks Method of treating acne vulgaris using avermectin compound
FR2830415B1 (fr) 2001-10-09 2004-07-09 Rhodia Chimie Sa Utilisation d'une composition a base de gomme xanthane en tant que stabilisant de mousses molles, et les mousses a base de cette composition
JP2006505583A (ja) * 2002-10-25 2006-02-16 フォーミックス エルティーディー. 化粧剤および医薬用フォーム
FR2854074B1 (fr) 2003-04-24 2007-11-23 Galderma Res & Dev Utilisation de l'ivermectine pour le traitement de desordres dermatologiques
US20050123487A1 (en) 2003-12-08 2005-06-09 Spadini Alessandro L. Stable nonaqueous liquid reactive skin care and cleansing packaged product
US20060057075A1 (en) 2004-08-02 2006-03-16 Moshe Arkin Pharmaceutical and cosmeceutical wash-off mousse shampoo compositions, processes for preparing the same and uses thereof
SI1791791T1 (sl) 2004-09-27 2019-10-30 Special Water Patents B V Postopki in sestavki za obdelavo vode
ES2582654T3 (es) 2006-03-31 2016-09-14 Stiefel Research Australia Pty Ltd Gel en suspensión espumable
WO2009069006A2 (en) 2007-11-30 2009-06-04 Foamix Ltd. Foam containing benzoyl peroxide
FR2924944A1 (fr) 2007-12-18 2009-06-19 Galderma Sa Composition a base d'une avermectine et du soufre ou d'un derive du soufre, notamment pour le traitement de la rosacee
US10589134B2 (en) 2008-01-30 2020-03-17 Kimberly-Clark Worldwide, Inc. Hand health and hygiene system for hand health and infection control
DE102008029357A1 (de) 2008-06-20 2009-12-24 Schwan-Stabilo Cosmetics Gmbh & Co. Kg Schäumende kosmetische Zubereitung
WO2010086725A1 (en) 2009-01-30 2010-08-05 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd Compositions for nail and skin treatment
FR2943914A1 (fr) * 2009-04-06 2010-10-08 Fabre Pierre Dermo Cosmetique Flacon mousseur comprenant une composition pharmaceutique
US20100291160A1 (en) 2009-05-13 2010-11-18 Carver David R Pharmaceutical system for trans-membrane delivery
US8637569B2 (en) 2009-10-22 2014-01-28 Api Genesis, Llc Methods of increasing solubility of poorly soluble compounds and methods of making and using formulations of such compounds
US20110236503A1 (en) 2010-03-23 2011-09-29 Cosmalabs International, Llc Topical Skincare Composition
CN104288768A (zh) 2010-06-30 2015-01-21 盖尔德马研究及发展公司 α2-肾上腺素能受体激动剂的用途
CN103118660B (zh) 2010-09-24 2016-03-16 大同化成工业株式会社 发泡型皮肤外用剂
FR2969493B1 (fr) 2010-12-23 2013-07-05 Galderma Res & Dev Mousses dermatologiques obtenues a partir d'un gel ou d'une suspension contenant du bpo
FR2969492B1 (fr) 2010-12-23 2013-07-05 Galderma Res & Dev Mousses dermatologiques obtenues a partir d'un gel ou d'une suspension contenant de l'adapalene
FR2969491B1 (fr) 2010-12-23 2013-07-12 Galderma Res & Dev Mousses dermatologiques obtenues a partir d'un gel ou d'une suspension contenant une combinaison d'adapalene et de bpo
US9301935B2 (en) 2013-06-10 2016-04-05 Naeem Uddin Broad spectrum pharmacological composition for treatment of various infections and diseases and methods of use
CA2915206A1 (en) 2013-06-17 2014-12-24 Contract Pharmaceuticals Limited Non-aerosol foams for topical administration
KR20160093069A (ko) * 2013-12-04 2016-08-05 갈데르마 리써어치 앤드 디벨로프먼트 레티노이드를 바람직하게 포함하는 지질 마이크로캡슐, 및 이를 포함하는 조성물, 이의 제조 방법, 및 피부과에 있어서의 이의 용도
ES2704264T3 (es) 2014-03-28 2019-03-15 Galderma Res & Dev Espuma química que se aclara que contiene peróxido de benzoilo
EP3122325B1 (fr) 2014-03-28 2018-10-31 Galderma Research & Development Mousse chimique non rincée contenant du peroxyde de benzoyle
CN104382863B (zh) 2014-11-29 2017-07-07 河南后羿实业集团有限公司 一种禽用伊维菌素泡腾颗粒
ITUB20161027A1 (it) * 2016-02-24 2017-08-24 Altergon Sa Preparazioni farmaceutiche oromucosali ad elevata biodisponibilita’ a base di ciclodestrina e sucralosio
MX2020012139A (es) 2016-09-08 2021-01-29 Vyne Pharmaceuticals Inc Composiciones y metodos para tratar rosacea y acne.
CN107312205B (zh) * 2017-06-15 2020-02-11 淮阴工学院 凹土负载壳聚糖交联环糊精复合物的制备及其应用

Also Published As

Publication number Publication date
JP2018529773A (ja) 2018-10-11
AU2016330790A1 (en) 2018-05-10
WO2017055297A1 (fr) 2017-04-06
FR3041535A1 (fr) 2017-03-31
EP3355859A1 (fr) 2018-08-08
US20180280298A1 (en) 2018-10-04
AU2016330790B2 (en) 2022-05-12
FR3041535B1 (fr) 2019-01-25
US11020348B2 (en) 2021-06-01
MX382168B (es) 2025-03-13
CN108289838A (zh) 2018-07-17
KR20180057713A (ko) 2018-05-30

Similar Documents

Publication Publication Date Title
MX2018003551A (es) Composicion limpiadora auto-espumante para enjuagar que contiene ivermectina.
BR112016022293A2 (pt) Composição que contém peróxido de benzoíla, uso cosmético de uma composição, medicamento destinado a uma aplicação tópica sobre a pele, kit e processo de preparação de uma composição autoespumante
UY36121A (es) ?pirazolopiridinas y pirazolopirimidinas?.
CL2020002444A1 (es) Usos de un inhibidor de masp-2 para proteger un riñón de nefropatía fármaco-inducida (divisional de la solicitud no. 201801817)
BR112016022340A2 (pt) Composição, uso cosmético de uma composição, medicamento e kit
MX2018003640A (es) Espuma quimica sin enguaje que contiene trifaroteno y su uso en el tratamiento de la ictiosis.
DOP2018000240A (es) Derivados de piridiniltriazol sustituidos con amida y usos de estos
MX2017016781A (es) Derivados de sulfamoilarilamida ciclados y su uso como medicamentos para el tratamiento de la hepatitis b.
MX2018003643A (es) Espuma quimica sin enguaje que contiene trifaroteno y su uso en el tratamiento del acne.
MX2016016216A (es) Metodo para el tratamiento del cabello con un acondicionador concentrado.
CR20140318A (es) Composiciones intranasales de dexmedetomidina y métodos de uso de ellas
UY37221A (es) Derivados de feniltriazol sustituidos con amida y usos de estos
UY36574A (es) Inhibidores de bromodominios
MX2023007405A (es) Regimen de cladribina para usarse en el tratamiento de formas progresivas de esclerosis multiple.
MX2018003642A (es) Espuma quimica sin enjuage que contiene propionato de clobetasol y su uso en el tratamiento de la psoriasis.
CL2017000329A1 (es) Mejorar el rendimiento miocárdico en pacientes con cirugía de fontan que utilizan composiciones de udenafilo
SV2018005701A (es) Compuestos de 1,3,4-tiadiazol y su uso en el tratamiento del cancer
MX2018003647A (es) Espuma quimica sin enjuague que contiene brimonidina y su uso en el tratamiento de la rosacea.
MX372970B (es) Espuma quimica sin enjuague que contiene adapaleno y peroxido de benzoilo.
MX2018003549A (es) Composicion limpiadora auto-espumante que contiene propionato de clobetasol y su uso en el tratamiento de la psoriaris.
MX2018003552A (es) Espuma quimica sin enjuague que comprende ivermectina.
SV2017005417A (es) Composición farmacéutica solida que comprende amlodipino y losartán
BR112016028662A2 (pt) composições herbicidas sólidas contendo um agente de proteção
MX2016012314A (es) Analagos de apelina ciclicos.
AR106271A1 (es) Composiciones para el cabello